Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
, 13 (1), 84-8

Loss of Tumor Suppressor PTEN Function Increases B7-H1 Expression and Immunoresistance in Glioma

Affiliations

Loss of Tumor Suppressor PTEN Function Increases B7-H1 Expression and Immunoresistance in Glioma

Andrew T Parsa et al. Nat Med.

Abstract

Cancer immunoresistance and immune escape may play important roles in tumor progression and pose obstacles for immunotherapy. Expression of the immunosuppressive protein B7 homolog 1 (B7-H1), also known as programmed death ligand-1 (PD-L1), is increased in many pathological conditions, including cancer. Here we show that expression of the gene encoding B7-H1 increases post transcriptionally in human glioma after loss of phosphatase and tensin homolog (PTEN) and activation of the phosphatidylinositol-3-OH kinase (PI(3)K) pathway. Tumor specimens from individuals with glioblastoma multiforme (GBM) had levels of B7-H1 protein that correlated with PTEN loss, and tumor-specific T cells lysed human glioma targets expressing wild-type PTEN more effectively than those expressing mutant PTEN. These data identify a previously unrecognized mechanism linking loss of the tumor suppressor PTEN with immunoresistance, mediated in part by B7-H1.

Similar articles

See all similar articles

Cited by 476 PubMed Central articles

See all "Cited by" articles

Publication types

MeSH terms

Feedback